Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
GALT similar filings
- 9 Nov 15 Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update
- 19 Oct 15 Regulation FD Disclosure
- 16 Sep 15 Galectin Therapeutics Announces Start of Phase 2 Clinical Trial with GR-MD-02 in NASH with Advanced Fibrosis
- 11 Sep 15 Changes in Registrant's Certifying Accountant
- 10 Sep 15 Regulation FD Disclosure
- 2 Sep 15 Regulation FD Disclosure
- 10 Aug 15 Galectin Therapeutics Provides Phase 2 NASH Program Update and Reports Second Quarter 2015
Filing view
External links
Exhibit 16.1
September 9, 2015
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read Galectin Therapeutics, Inc.’s statements included under Item 4.01 of its Form 8-K to be filed on September 11, 2015 and we agree with such statements concerning our firm.
/s/ McGladrey LLP
McGladrey LLP